Cited by 25Chemotherapy-induced organ toxicity mitigationDrug-Induced Hepatotoxicity and ProtectionChemotherapy-induced cardiotoxicity and mitigation

Epigallocatechin gallate and coenzyme Q10 attenuate cisplatin‐induced hepatotoxicity in rats via targeting mitochondrial stress and apoptosis

Fatima, Sabiha, Suhail, Nida, Alrashed, May, Wasi, Samina, Aljaser, Feda S., AlSubki, Roua A., Alsharidah, Ashwag S., Banu, Naheed·2021·Journal of Biochemical and Molecular Toxicology

Abstract

Despite the extensive use of cisplatin (CP) as a chemotherapeutic agent, its clinical use is often restricted by undesirable side effects, such as toxicity to normal tissues. The aim of this study was to probe the effect of a combinatorial treatment of low multiple doses of antioxidants on CP‐induced toxicity and the mitochondrial apoptotic pathway in hepatocytes. Animals received a single toxic dose of CP (7.5 mg/kg body weight) with or without combined multiple doses of epigallocatechin gallate (EGCG) and coenzyme Q10 (CoQ10) (15 and 5 mg/kg body weight, respectively). CP‐treated animals showed altered biochemical parameters, denoting hepatotoxicity, which was markedly improved by the multidose treatment with EGCG + CoQ10. The increased levels of oxidants found in the cytosolic and mitochondrial fractions isolated from the liver of CP‐administered rats were significantly attenuated by the combinatorial doses of antioxidants. EGCG + CoQ10 ameliorated the CP‐induced compromised antioxidant defenses, oxidative modification of macromolecules, decreased activities of respiratory chain enzymes, altered membrane depolarization, and swelling of liver mitochondria. Furthermore, EGCG + CoQ10 treatment inhibited CP‐induced apoptosis by suppressing the activation and mitochondrial accumulation of proapoptotic proteins and preventing the inhibition of antiapoptotic protein expression, cytochrome c efflux, caspase‐3 activation, and DNA fragmentation. Histological findings further confirmed the protective effects of EGCG + CoQ10 against CP‐induced cellular injury. Our findings revealed that the combination of EGCG and CoQ10, owing to their individual antioxidant properties, can be an effective remedy, which by maintaining redox hemostasis attenuate the mitochondrial stress‐mediated molecular and cellular processes involved in CP‐induced liver toxicity and cell death.

Integrity signals

Registry

Crossref · 10.1002/jbt.22701

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CoQ10 inhibits activation of caspase-3 and release of cytochrome c from mitochondria by stabilizing the mitochondrial membrane, suppresses proapoptotic genes caspase-3 and Bax, stimulates antiapoptotic Bcl2, and prevents translocation of nuclear apoptosis-inducing factors.

    “This is in line with Sumi et al. (2018) and Fatima et al. (2021) who stated that CoQ10 inhibited the activation of caspase-3 and the release of cytochrome c from mitochondria via stabilizing the mitochondrial membrane, thus preventing the release of apoptotic mediators.”

    From Can coenzyme Q10 alleviate the toxic effect of fenofibrate on skeletal muscle? (2023) · cites this paper as Fatima et al. 2021

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fatima, S., Suhail, N., Alrashed, M., Wasi, S., Aljaser, F. S., AlSubki, R. A., Alsharidah, A. S., & Banu, N.
Affiliations
  • King Saud University (SA)
  • Northern Border University (SA)
  • Imam Abdulrahman Bin Faisal University (SA)
  • Qassim University (SA)
Corresponding author
Fatima, Sabiha
Venue
Journal of Biochemical and Molecular Toxicology
Publisher
Wiley
Published
2021-01-04
Volume
35
Issue
4
Pages
e22701-e22701
ISSN
  • 0887-2082 (ISSN-L)
  • 1095-6670
  • 1099-0461
OpenAlex
W3120796915
Cited by
25
References
52
Citations by year
2026: 4 · 2025: 9 · 2024: 2 · 2023: 5 · 2022: 5
FWCI
2.00
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Biochemical and Molecular Toxicology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Chemotherapy-induced organ toxicity mitigation
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
Keywords
cisplatin, hepatotoxicity, epigallocatechin gallate, coenzyme Q10, mitochondrial stress, apoptosis, oxidative stress, antioxidants, caspase-3, mitochondrial depolarization, hepatoprotection, redox homeostasis, chemotherapy-induced liver injury
MeSH terms
Animals, Catechin, Cisplatin, Liver, Male, Mitochondria, Liver, Ubiquinone, Rats, Wistar, Apoptosis, Oxidative Stress, Hepatocytes, Rats, Chemical and Drug Induced Liver Injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review